Donor support for Health Policy and Systems Research: barriers to financing and opportunities for overcoming them.

Donor priorities Global health financing Health Policy and Systems Research (HPSR) Health Systems

Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
23 12 2022
Historique:
received: 02 02 2022
accepted: 21 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 28 12 2022
Statut: epublish

Résumé

The vast investments that have been made in recent decades in new medicines, vaccines, and technologies will only lead to improvements in health if there are appropriate and well-functioning health systems to make use of them. However, despite the growing acceptance by major global donors of the importance of health systems, there is an enthusiasm gap when it comes to disbursing funds needed to understand the intricacies of how, why and when these systems deliver effective interventions. To understand the reasons behind this, we open up the black box of donor decision-making vis-à-vis Health Policy and Systems Research (HPSR) financing: what are the organizational processes behind the support for HPSR, and what are the barriers to increasing engagement? We conducted 27 semi-structured interviews with staff of major global health funders, asking them about four key issues: motivations for HPSR financing; priorities in HPSR financing; barriers for increasing HPSR allocations; and challenges or opportunities for the future. We transcribed the interviews and manually coded responses. Our findings point to the growing appreciation that funders have of HPSR, even though it is often still seen as an 'afterthought' to larger programmatic interventions. In identifying barriers to funding HPSR, our informants emphasised the perceived lack of mandate and capacities of their organizations. For most funding organisations, a major barrier was that their leadership often voiced scepticism about HPSR's long time horizons and limited ability to quantify results. Meeting contemporary health challenges requires strong and effective health systems. By allocating more resources to HPSR, global donors can improve the quality of their interventions, and also contribute to building up a stock of knowledge that domestic policymakers and other funders can draw on to develop better targeted programmes and policies.

Sections du résumé

BACKGROUND
The vast investments that have been made in recent decades in new medicines, vaccines, and technologies will only lead to improvements in health if there are appropriate and well-functioning health systems to make use of them. However, despite the growing acceptance by major global donors of the importance of health systems, there is an enthusiasm gap when it comes to disbursing funds needed to understand the intricacies of how, why and when these systems deliver effective interventions. To understand the reasons behind this, we open up the black box of donor decision-making vis-à-vis Health Policy and Systems Research (HPSR) financing: what are the organizational processes behind the support for HPSR, and what are the barriers to increasing engagement?
METHODS
We conducted 27 semi-structured interviews with staff of major global health funders, asking them about four key issues: motivations for HPSR financing; priorities in HPSR financing; barriers for increasing HPSR allocations; and challenges or opportunities for the future. We transcribed the interviews and manually coded responses.
RESULTS
Our findings point to the growing appreciation that funders have of HPSR, even though it is often still seen as an 'afterthought' to larger programmatic interventions. In identifying barriers to funding HPSR, our informants emphasised the perceived lack of mandate and capacities of their organizations. For most funding organisations, a major barrier was that their leadership often voiced scepticism about HPSR's long time horizons and limited ability to quantify results.
CONCLUSION
Meeting contemporary health challenges requires strong and effective health systems. By allocating more resources to HPSR, global donors can improve the quality of their interventions, and also contribute to building up a stock of knowledge that domestic policymakers and other funders can draw on to develop better targeted programmes and policies.

Identifiants

pubmed: 36564847
doi: 10.1186/s12992-022-00896-4
pii: 10.1186/s12992-022-00896-4
pmc: PMC9782264
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2022. The Author(s).

Références

Lancet Glob Health. 2020 Jun;8(6):e738-e739
pubmed: 32389194
J Int AIDS Soc. 2016 Jul 20;19(5 Suppl 4):20842
pubmed: 27443272
Health Policy Plan. 2022 Dec 22;:
pubmed: 36546732
Bull World Health Organ. 2016 Jan 1;94(1):2
pubmed: 26769987
Health Res Policy Syst. 2017 Aug 31;15(1):68
pubmed: 28854946
Health Res Policy Syst. 2020 Jan 13;18(1):4
pubmed: 31931821
Health Res Policy Syst. 2018 May 23;16(1):43
pubmed: 29792204
J Health Commun. 2005 Mar;10(2):163-80
pubmed: 15804906
Glob Public Health. 2014;9(8):865-79
pubmed: 25156323
Implement Sci. 2014 Oct 08;9:150
pubmed: 25294279
Lancet. 2008 Jul 12;372(9633):95-97
pubmed: 18620934
Lancet. 2020 Mar 14;395(10227):848-850
pubmed: 32151326
Health Policy Plan. 2013 Jan;28(1):41-50
pubmed: 22407017
Int J Health Policy Manag. 2018 Dec 22;8(4):191-194
pubmed: 31050963
Health Policy Plan. 2018 Mar 1;33(2):215-223
pubmed: 29237026
Health Res Policy Syst. 2018 Aug 22;16(1):84
pubmed: 30134979
Bull World Health Organ. 2016 Jul 1;94(7):491-500
pubmed: 27429488
BMJ. 2021 Apr 27;373:n1052
pubmed: 33906903
Public Health Res Pract. 2017 Feb 15;27(1):
pubmed: 28243669
Bull World Health Organ. 2014 Dec 1;92(12):851
pubmed: 25552766
Malar J. 2014 Aug 08;13:305
pubmed: 25107509
Global Health. 2020 Nov 19;16(1):112
pubmed: 33213482
Int J Equity Health. 2018 Sep 27;17(1):155
pubmed: 30261882
Soc Sci Med. 2011 Jul;73(1):33-41
pubmed: 21680070

Auteurs

Alexander Kentikelenis (A)

Department of Social and Political Sciences, Bocconi University, via Roentgen 1, 20136, Milano, Italy. alexander.kentikelenis@unibocconi.it.

Abdul Ghaffar (A)

Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.

Martin McKee (M)

London School of Hygiene and Tropical Medicine, London, UK.

Livia Dal Zennaro (L)

Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.

David Stuckler (D)

Department of Social and Political Sciences, Bocconi University, via Roentgen 1, 20136, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH